A Phase III Study of Conventional Radiation Therapy Plus Thalidomide (NSC#66847) Versus Conventional Radiation Therapy for Multiple Brain Metastases

Trial Profile

A Phase III Study of Conventional Radiation Therapy Plus Thalidomide (NSC#66847) Versus Conventional Radiation Therapy for Multiple Brain Metastases

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Jun 2013

At a glance

  • Drugs Thalidomide (Primary)
  • Indications Advanced breast cancer; Brain cancer; Cancer; Cancer metastases; Lung cancer; Skin cancer
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 01 May 2008 Results have been published
    • 13 Feb 2007 The expected completion date for this trial is now .
    • 24 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top